PI Pembro in Combination With Stereotactic Body Radiotherapy for Liver Metastatic Colorectal Cancer

NCT02837263 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer
Colorectal Adenocarcinoma
Stage IVA Colorectal Cancer
Stage IVB Colorectal Cancer
Metastatic Carcinoma in the Liver

Interventions

RADIATION: Stereotactic body radiotherapy (SBRT)
DRUG: Pembrolizumab

Sponsor

University of Wisconsin, Madison

Collaborators

[object Object]